Get my own profile
Public access
View all15 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Rodolfo A. MartinezSpinCeuticaVerified email at millent.com
- Louis SilksLos Alamos National LaboratoryVerified email at lanl.gov
- Basil SwansonLos Alamos, Austin Texas, Bronx New York, Evanston IllinoisVerified email at lanl.gov
- David Renwick HouckCEO Pharmakey LLCVerified email at pharmakey.com
- William S. HlavacekTheoretical Division, Los Alamos National LaboratoryVerified email at lanl.gov
- Tom PeatUNSWVerified email at unsw.edu.au
- Janet NewmanScientist, CSIROVerified email at csiro.au
- Ian HolmesProfessor, Computational Biology and Bioengineering, UC BerkeleyVerified email at berkeley.edu
- Michael A. KennedyMiami UniversityVerified email at miamioh.edu
- David T FoxLos Alamos National LaboratoryVerified email at lanl.gov
- Greg McMahonNational Physcial Laboratory UKVerified email at npl.co.uk
- Brian CarrollScientist Manager, Primus PharamceuticalsVerified email at primusrx.com
- Taraka DaleLos Alamos National LaboratoryVerified email at lanl.gov
- David O'HaganUniversity of St AndrewsVerified email at st-andrews.ac.uk
- Karissa SanbonmatsuPrincipal Investigator, Los Alamos National LaboratoryVerified email at lanl.gov
- Donald K. BlumenthalUniversity of UtahVerified email at pharm.utah.edu
- Tuhin MaityPDCI Market Access and McMaster UniversityVerified email at mcmaster.ca
- Farol L. TomsonMSDVerified email at mesoscale.com
- R. Brian DyerEmory UniversityVerified email at emory.edu
- James R FaederUniversity of PittsburghVerified email at pitt.edu